Enhanced gene expression of Na(+)/Ca(2+) exchanger attenuates ischemic and hypoxic contractile dysfunction

Area of Science:

• Cardiovascular Physiology
• Molecular Cardiology
• Biomedical Engineering

Background:

• Failing hearts exhibit impaired sarcoplasmic reticulum (SR) calcium (Ca(2+)) transport.
• Enhanced Na(+)/Ca(2+) exchanger (NCX) gene expression may compensate for SR dysfunction.
• Investigating NCX's role in preserving cardiac function under stress is crucial.

Purpose of the Study:

• To determine if enhanced Na(+)/Ca(2+) exchanger expression preserves intracellular calcium (Ca(i)(2+)) homeostasis and cardiac function during ischemia and hypoxia.
• To compare the effects of ischemia and hypoxia on transgenic mouse hearts overexpressing the Na(+)/Ca(2+) exchanger versus wild-type hearts.

Main Methods:

• Utilized genetically engineered mouse hearts overexpressing the Na(+)/Ca(2+) exchanger.
• Monitored intracellular calcium (Ca(i)(2+)) levels and cardiac function (pressure-generating capacity) during induced ischemia and hypoxia.
• Compared physiological responses between transgenic and wild-type hearts.

Main Results:

• Transgenic hearts maintained significantly better Ca(i)(2+) levels and 40% of pressure-generating capacity during early ischemia compared to wild-type hearts (25%).
• During hypoxia, transgenic hearts showed preserved peak and diastolic Ca(i)(2+), with only a ~10% decrease in peak systolic pressure.
• Wild-type hearts exhibited significant declines in Ca(i)(2+) and >25% reduction in peak systolic pressure under hypoxia.

Conclusions:

• Enhanced Na(+)/Ca(2+) exchanger gene expression effectively preserves Ca(i)(2+) homeostasis during acute cardiac stress (ischemia and hypoxia).
• This preservation of calcium handling translates to improved cardiac function in the setting of an acutely failing heart.
• Targeting the Na(+)/Ca(2+) exchanger may represent a viable therapeutic strategy for managing acute heart failure.